J2246 – Injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ2246
- Long description
- Injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mg
- Short description
- Inj, micafungin (baxter)
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- Added
- July 1, 2024
- Last change
- July 1, 2024 – No change
Frequently asked questions
What is HCPCS code J2246?
J2246 is a HCPCS Level II code for injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mg.
Does Medicare cover J2246?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J2180 – Injection, meperidine and promethazine hcl, up to 50 mg
- J2182 – Injection, mepolizumab, 1 mg
- J2183 – Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg
- J2184 – Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg
- J2185 – Injection, meropenem, 100 mg
- J2186 – Injection, meropenem and vaborbactam, 10mg/10mg (20mg)
- J2210 – Injection, methylergonovine maleate, up to 0.2 mg
- J2212 – Injection, methylnaltrexone, 0.1 mg
- J2247 – Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mg
- J2248 – Injection, micafungin sodium, 1 mg
- J2249 – Injection, remimazolam, 1 mg
- J2250 – Injection, midazolam hydrochloride, per 1 mg
- J2251 – Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
- J2252 – Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
- J2253 – Injection, midazolam (seizalam), 1 mg
- J2260 – Injection, milrinone lactate, 5 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.